Geoffrey R. Erickson

Founder at Immunis.AI, Inc.

Finance

Consumer Services

Health Technology

Profile

Dr. Geoffrey R.
Erickson is a Director-Business Development at Office of Technology Development.
Prior to joining OTD in 2009, he was CEO of Humacyte, Inc., a company created from technology out of Duke University and MIT.
Prior to his role at Humacyte, Dr. Erickson was a venture capitalist with Pappas Ventures, a firm focused on investments in the life science industry which he joined in 2001.
In addition, he worked with Pappas Ventures as a co-founder of CoLucid Pharmaceuticals.
Dr. Erickson received a BSE in engineering from Duke University, an MSE in engineering from Tulane University, and a PhD in biomedical engineering from Duke University.

Geoffrey R. Erickson active positions

Companies	Position	Start
Immunis.AI, Inc. Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis.	Founder	-

All active positions of Geoffrey R. Erickson

Former positions of Geoffrey R. Erickson

Companies	Position	End
Humacyte Global, Inc. Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC.	President	2008-12-30
Pappas Capital LLC Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.	Private Equity Analyst	2007-12-30
Office of Technology Development Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts.	Corporate Officer/Principal	-

See the detail of Geoffrey R. Erickson's experience

Training of Geoffrey R. Erickson

Duke University	Doctorate Degree
Tulane University (Louisiana)	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Geoffrey R. Erickson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Humacyte Global, Inc. Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC.	Health Technology
Pappas Capital LLC Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.	Finance
Office of Technology Development Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts.	Finance
Immunis.AI, Inc. Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis.	Technology Services

See company connections